FIELD: medicine. SUBSTANCE: method involves administering the medicament for treating the cases of gastric and duodenal peptic ulcer disease. EFFECT: enhanced effectiveness of treatment; avoided adverse side effects. 3 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PEPTIC ULCERS | 1994 |
|
RU2098098C1 |
ANTI-ULCER MEDICATION | 2011 |
|
RU2473336C1 |
METHOD OF PREPARING SUBSTANCE SHOWING ANTIULCER ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1993 |
|
RU2071343C1 |
ANTIULCER AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2141332C1 |
ANTIULCER AGENT AND METHOD OF ITS PREPARING | 1996 |
|
RU2146936C1 |
THERAPY METHOD FOR SLUGGISH ULCERS AND EROSIONS IN GASTRODUODENAL SYSTEM | 2003 |
|
RU2261091C2 |
SPLENOTHERAPY METHOD FOR TREATING GASTRODUODENAL ULCERS | 2001 |
|
RU2179858C1 |
METHOD OF TREATMENT OF PATIENTS WITH DUODENUM ULCER DISEASE OF MODERATE SEVERITY | 2000 |
|
RU2173991C1 |
THERAPY OF DUODENAL ULCER OF MEDIUM SEVERITY | 2008 |
|
RU2364410C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF EROSIVE AND ULCERATIVE LESIONS OF THE STOMACH AND DUODENUM | 2021 |
|
RU2763754C1 |
Authors
Dates
2002-06-20—Published
2000-07-10—Filed